Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product (Marketwire via Yahoo! Finance)
Endo Pharmaceuticals Holdings Inc., a market leader in pain management, today announced that it has entered into a license and development agreement with Alexza Pharmaceuticals, Inc. for the exclusive clinical development and commercialization rights in North America for Alexza's AZ-003 (Staccato fentanyl).

NeuroMetrix Completes the Acquisition of the Assets of EyeTel Imaging; Looks to Expand Market Opportunity for the ... (Finanzen.net)
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and ...

NeuroMetrix Completes the Acquisition of the Assets of EyeTel Imaging; Looks to Expand Market Opportunity for the ... (Centre Daily Times)
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain, announced today that it has acquired substantially all of the assets of EyeTel Imaging, Inc. ("EyeTel") and has assumed certain specified liabilities in ...